Anna Guidetti
Impact in
-
- Lymphoma Diagnosis and Treatment
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- Lymphoma Diagnosis and Treatment 32
- Hematology 12
- Multiple Myeloma Research and Treatments 6
- Hematopoietic Stem Cell Transplantation 6
- Co-authors
- Carmelo Carlo‐Stella (38 shared papers)Alessandro M. Gianni (30 shared papers)Paolo Corradini (36 shared papers)Massimo Di Nicola (27 shared papers)Michele Magni (18 shared papers)Paola Matteucci (17 shared papers)Liliana Franca Devizzi (18 shared papers)Lucia Farina (12 shared papers)
In The Last Decade
Anna Guidetti
92 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 40
- Pathology and Forensic Medicine 435
- Infectious Diseases 356
- Genetics 128
- Hematology 191
- Oncology 197
Countries citing papers authored by Anna Guidetti
This map shows the geographic impact of Anna Guidetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Guidetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Guidetti more than expected).
Fields of papers citing papers by Anna Guidetti
This network shows the impact of papers produced by Anna Guidetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Guidetti. The network helps show where Anna Guidetti may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Guidetti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 98 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 243 | |
| 2 | 2022 | 95 | |
| 3 | 2021 | 78 | |
| 4 | 2004 | 71 | |
| 5 | 2021 | 69 | |
| 6 | 2022 | 66 | |
| 7 | 2021 | 65 | |
| 8 | 2022 | 63 | |
| 9 | 2018 | 59 | |
| 10 | 2021 | 58 | |
| 11 | 2022 | 55 | |
| 12 | 2008 | 53 | |
| 13 | 2006 | 50 | |
| 14 | 2004 | 43 | |
| 15 | 2012 | 40 | |
| 16 | 2021 | 40 | |
| 17 | 2004 | 39 | |
| 18 | 2013 | 39 | |
| 19 | 2019 | 36 | |
| 20 | 2014 | 31 |
About Anna Guidetti
Anna Guidetti is a scholar working on Pathology and Forensic Medicine, Hematology, Oncology, Infectious Diseases and Genetics, having authored 98 papers that have together received 2.0k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (32 papers), CAR-T cell therapy research (11 papers), COVID-19 Clinical Research Studies (7 papers), Multiple Myeloma Research and Treatments (6 papers), Hematopoietic Stem Cell Transplantation (6 papers), Chronic Lymphocytic Leukemia Research (2 papers), Radiopharmaceutical Chemistry and Applications (2 papers) and Immunotherapy and Immune Responses (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (435 citations), Infectious Diseases (356 citations), Genetics (128 citations), Hematology (191 citations) and Oncology (197 citations). Anna Guidetti has collaborated with scholars based in Italy, Germany and Spain. Frequent co-authors include Carmelo Carlo‐Stella, Alessandro M. Gianni, Paolo Corradini, Massimo Di Nicola, Michele Magni, Paola Matteucci, Liliana Franca Devizzi, Lucia Farina, Anna Dodero and Loredana Cleris. Their work appears in journals such as Blood, British Journal of Haematology, Hematological Oncology, Blood Advances and HemaSphere.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.